Caldwell Sutter Capital’s Celldex Therapeutics CLDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-350
| Closed | -$6.35K | – | 866 |
|
2025
Q1 | $6.35K | Hold |
350
| – | – | ﹤0.01% | 597 |
|
2024
Q4 | $8.85K | Hold |
350
| – | – | ﹤0.01% | 567 |
|
2024
Q3 | $11.9K | Hold |
350
| – | – | 0.01% | 541 |
|
2024
Q2 | $13K | Hold |
350
| – | – | 0.01% | 529 |
|
2024
Q1 | $14.7K | Hold |
350
| – | – | 0.01% | 504 |
|
2023
Q4 | $13.9K | Hold |
350
| – | – | 0.01% | 505 |
|
2023
Q3 | $9.63K | Hold |
350
| – | – | 0.01% | 536 |
|
2023
Q2 | $11.9K | Hold |
350
| – | – | 0.01% | 506 |
|
2023
Q1 | $12.6K | Hold |
350
| – | – | 0.01% | 381 |
|
2022
Q4 | $15.6K | Buy |
+350
| New | +$15.6K | 0.01% | 237 |
|